Evidence map›Paper›PMID 25933938›Full record

ReviewAdvanced drug delivery reviews2015

Vaginal drug distribution modeling.

David F Katz, Andrew Yuan, Yajing Gao

Abstract readReview
In one paragraph

Review in Advanced drug delivery reviews, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Drug and therapeutic intravaginal delivery targeting diseases in the female reproductive tract: A mathematical modeling perspective.Journal of controlled release : official journal of the Controlled Release Society · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David F KatzDepartment of Biomedical Engineering, Duke University, Durham, NC, USA; Department of Obstetrics and Gynecology, Duke University, Durham, NC USA. Electronic address: dkatz@duke.edu.
Andrew YuanDepartment of Biomedical Engineering, Duke University, Durham, NC, USA.
Yajing GaoDepartment of Biomedical Engineering, Duke University, Durham, NC, USA.

Funding

Scientific CoreU19AI101961 · NIAID · IMQUEST BIOSCIENCES · PI KATZ, DAVID FRANK · 2012 to 2016
$14.3M
Preclinical User Accptability Studies Long Acting Vaginal Gels, Intravaginal RingU19AI077289 · NIAID · IMQUEST BIOSCIENCES · PI BUCKHEIT, ROBERT WALTER · 2008 to 2012
$6.7M
Novel Determination of Microbicide PK in Women's Reproductive HealthR01HD072702 · NICHD · DUKE UNIVERSITY · PI KATZ, DAVID FRANK · 2012 to 2015
$1.8M
NIAID NIH HHS AI 077289NIAID NIH HHS U19 AI077289NIAID NIH HHS U19 AI101961NICHD NIH HHS HD 072702NICHD NIH HHS R01 HD072702
6 · The paper itself

Abstract

This review presents and applies fundamental mass transport theory describing the diffusion and convection driven mass transport of drugs to the vaginal environment. It considers sources of variability in the predictions of the models. It illustrates use of model predictions of microbicide drug concentration distribution (pharmacokinetics) to gain insights about drug effectiveness in preventing HIV infection (pharmacodynamics). The modeling compares vaginal drug distributions after different gel dosage regimens, and it evaluates consequences of changes in gel viscosity due to aging. It compares vaginal mucosal concentration distributions of drugs delivered by gels vs. intravaginal rings. Finally, the modeling approach is used to compare vaginal drug distributions across species with differing vaginal dimensions. Deterministic models of drug mass transport into and throughout the vaginal environment can provide critical insights about the mechanisms and determinants of such transport. This knowledge, and the methodology that obtains it, can be applied and translated to multiple applications, involving the scientific underpinnings of vaginal drug distribution and the performance evaluation and design of products, and their dosage regimens, that achieve it.

Indexed as

Models, BiologicalAnti-HIV AgentsDrug StabilityFemaleHIV InfectionsHumansVaginaVaginal AbsorptionVaginal Creams, Foams, and JelliesViscosityAnti-HIV AgentsVaginal Creams, Foams, and JelliesGelHIVMicrobicidesModelingMucosaRingVagina

Identifiers

PMID25933938
PMCPMC4600641

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.